MET As a Potential Target for the Treatment of Upper Gastrointestinal Cancers: Characterization of Novel c-Met Inhibitors from Bench to Bedside

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|8|975-989

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.8, 2014-01, pp. : 975-989

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of c-MET pathway inhibitors

By Liu Xiangdong   Newton Robert C   Scherle Peggy A  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. : 1225-1241

Informa Healthcare

Access to resources Recommend Favorite

Targeting c-MET/HGF Signaling Pathway in Upper Gastrointestinal Cancers: Rationale and Progress

By  

Current Drug Targets, Vol. 15, Iss. 14, 2014-12 ,pp. : 1302-1311

Bentham Science Publishers

Access to resources Recommend Favorite

C-Met Inhibitors are Potential Novel Therapeutic Agents Against Listeria monocytogenes Infection Through Blocking the Bacteria Entry into Nonphagocytic Cells

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 278-289

Bentham Science Publishers

Access to resources Recommend Favorite

Novel peptides targeting the hepatocyte growth factor receptor c-Met for the treatment of cancer

By Michaud Neil R  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 5, 2005-05 ,pp. : 621-625

Informa Healthcare

Access to resources Recommend Favorite

Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside

By Vincenzi Bruno   Napolitano Andrea   D'Onofrio Loretta   Frezza Anna Maria   Silletta Marianna   Venditti Olga   Santini Daniele   Tonini Giuseppe  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1685-1705

Informa Healthcare

Access to resources Recommend Favorite